Gilead Sciences Inc is in talks with chemical and drug makers to produce its experimental drug remdesivir, a potential coronavirus treatment, for Europe, Asia and the developing world, the firm has said.
FILE PHOTO: A lab technician visually inspects a filled vial of investigational coronavirus disease treatment drug remdesivir at a Gilead Sciences facility in La Verne, California, U.S. March 11, 2020. Picture taken March 11, 2020. Gilead Sciences Inc/Handout via REUTERS
The countries are: Afghanistan; Angola; Bangladesh; Benin; Burkina Faso; Burundi; Cambodia; Central African Republic; Chad; Democratic Republic of the Congo; Djibouti; Gambia; Guinea; Guinea Bissau; Haiti; Lao People’s Democratic Republic; Lesotho; Liberia; Madagascar; Malawi; Mali; Mauritania; Mozambique; Myanmar; Nepal; Niger; Rwanda; Senegal; Sierra Leone; Solomon Islands; Tanzania; Togo; Uganda; Vanuatu; Yemen and Zambia.
Indian drugmakers, a key supplier of cheap medicines to the world, have also struck licensing deals. Gilead issued voluntary licenses
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Coronavirus Disease 2019 (COVID-19)First Responders/Health Providers: New CDC instructional videos show how to safely put on (don) and take off (doff) recommended PPE for caring for COVID19 patients. To see the videos and learn more, please visit:
Read more »
Coronavirus Disease 2019 (COVID-19)DYK: People with asthma may be at higher risk of getting very sick from COVID19. Wearing a face covering can help protect those around you who may be at higher risk. Learn more from CDCgov: WorldAsthmaDay
Read more »
Prostate-cancer men swap chemo for precision drugsMen with advanced prostate cancer can now take highly targeted hormone therapies at home.
Read more »
More than half of Americans now use contactless payments, according to Mastercard pollThe ongoing coronavirus pandemic has bolstered the number of Americans using contactless payments to 51%, according to a new Mastercard poll.
Read more »
I Haven't Worn A Bra For Weeks. Is This A Bad Idea?Experts reveal whether a free-range life during the coronavirus pandemic is good for your breast health.
Read more »
'Call of Duty' publisher Activision funding coronavirus drug research - Business InsiderThe latest 'Call of Duty' has been a sales smash as many people are stuck indoors. Now, its publisher is funding coronavirus-fighting drugs.
Read more »